The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023–2024)

Overall detection rates of gPVs are similar to those reported elsewhere from Jewish population testing. The pathway, particularly for males, may attract uptake of testing by those previously aware of familial gPVs.

Authors

Institutions

Publication Details

Journal
Journal of Medical Genetics
Published
2024-12-22
DOI
https://doi.org/10.1136/jmg-2024-110390
Citations
5
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
2.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023–2024)

Angela George, Emily Watts, Mikel Valganon-Petrizan, Lisa Steele et al.
5 citations
Journal of Medical Genetics
BRCA gene mutations in cancer
2.75
article

The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023–2024)

Angela George, Emily Watts, Mikel Valganon-Petrizan, Lisa Steele, Monica Hamill, Ranjit Manchanda, Sonja Lukić, Ruth McCarthy, Yasmin Clinch, Bethany Torr, P. Thomas . Auteur du texte Ryves, Nicole A. Gordon, Shrikanth Muralidharan, George J. Burghel, Nicola Bell, Pooja Dasani, Colm Andrews, Alison Morilla, Hélene Schlecht, Joshua Nolan, D. Gareth Evans, Suzanne MacMahon, Moses Adegoroye, Wendy Ornadel
article en
5 citations

Abstract

Overall detection rates of gPVs are similar to those reported elsewhere from Jewish population testing. The pathway, particularly for males, may attract uptake of testing by those previously aware of familial gPVs.

Journal of Medical GeneticsVol. 62(2)
Royal Marsden NHS Foundation Trust (GB), Institute of Cancer Research (GB), Queen Mary University of London (GB), Barts Health NHS Trust (GB), Great Ormond Street Hospital for Children NHS Foundation Trust (GB), University of Manchester (GB), London Cancer (GB), Manchester University NHS Foundation Trust (GB), Genomics (United Kingdom) (GB), NHS England
AstraZeneca, Royal Marsden NHS Foundation Trust, Barts Charity, National Institute for Health and Care Research, Department of Health and Social Care, Rosetrees Trust, Israel National Institute for Health Policy Research, Manchester Biomedical Research Centre, National Institute on Aging
Openalex Percentile: Top 9%
BRCA gene mutations in cancer
2.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.